These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10523238)

  • 1. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis.
    Brion PH; Mittal-Henkle A; Kalunian KC
    Ann Intern Med; 1999 Oct; 131(8):634. PubMed ID: 10523238
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatological complications of etanercept therapy for rheumatoid arthritis.
    Misery L; Perrot JL; Gentil-Perret A; Pallot-Prades B; Cambazard F; Alexandre C
    Br J Dermatol; 2002 Feb; 146(2):334-5. PubMed ID: 11903255
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cutaneous lupus induced by etanercept in rheumatoid arthritis].
    Abourazzak FE; Guggenbuhl P; Perdriger A; Meadeb J; Gando-Cocley N; Chevrant-Breton J; Hajjaj-Hassouni N; Chalès G
    Rev Med Interne; 2008 Sep; 29(9):744-7. PubMed ID: 18676065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA; Werth VP; Schumacher HR
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.
    Cairns AP; Duncan MK; Hinder AE; Taggart AJ
    Ann Rheum Dis; 2002 Nov; 61(11):1031-2. PubMed ID: 12379532
    [No Abstract]   [Full Text] [Related]  

  • 7. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K; Kawakami A; Hayashi T; Iwamoto N; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
    Mor A; Bingham CO; Barisoni L; Lydon E; Belmont HM
    J Rheumatol; 2005 Apr; 32(4):740-3. PubMed ID: 15801034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
    Nakahigashi K; Egawa G; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2014 Mar; 94(2):239-40. PubMed ID: 23824408
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffuse skin reaction after changing the etanercept formulation.
    Caporali R; Bobbio-Pallavicini F; Caprioli M; Scorletti E; Montecucco C
    Clin Exp Rheumatol; 2008; 26(6):1165. PubMed ID: 19210894
    [No Abstract]   [Full Text] [Related]  

  • 12. Granulomatous tattoo reaction in a patient treated with etanercept.
    Bachmeyer C; Blum L; Petitjean B; Kemiche F; Pertuiset E
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):550-2. PubMed ID: 17373994
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse dermatological reactions in rheumatoid arthritis patients treated with etanercept, an anti-TNFalpha drug.
    Rajakulendran S; Deighton C
    Curr Drug Saf; 2006 Aug; 1(3):259-64. PubMed ID: 18690936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
    Lai-Cheong J; Warren R; Bucknall R; Parslew R
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
    Livermore PA; Murray KJ
    Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
    Rajakulendran S; Deighton C
    Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukocytoclastic Vasculitis and Dermal Perivascular Hemophagocytosis Associated With Adalimumab Therapy for Rheumatoid Arthritis.
    Muto J; Usami J; Watanabe D
    Am J Dermatopathol; 2018 Jan; 40(1):57-59. PubMed ID: 28719435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocytoclastic vasculitis associated with golimumab.
    Pàmies A; Castro S; Poveda MJ; Fontova R
    Rheumatology (Oxford); 2013 Oct; 52(10):1921-3. PubMed ID: 23530254
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoriasiform and pustular eruption induced by etanercept and infliximab.
    Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
    Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneous vasculitis due to hypersensitivity probably caused by ketorolac trometamol].
    Barroso Casamitjana E; Isla Tejera B; Ruano Ruiz J; Blanco-Molina A
    Farm Hosp; 2006; 30(1):60-2. PubMed ID: 16569187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.